Low GI70 Soba is designed to support individuals managing blood sugar levels while delivering essential nutrients.
In an era where health-conscious consumers are increasingly seeking functional foods, Low GI70 Soba emerges as a groundbreaking product from Hebei Jinxu Noodles Co., Ltd. This low glycemic index (GI) noodle is engineered to provide a balanced nutritional profile while addressing the needs of individuals with diabetes, pre-diabetes, and those seeking to manage their blood sugar levels. With its unique formulation and scientific backing, Low GI70 Soba represents a significant advancement in the food industry.
Low GI70 Soba is a specialized noodle product that combines traditional ingredients with modern nutritional science. The product is formulated with 70% buckwheat, konjac, green barley, and tartary buckwheat, all of which are known for their health benefits. The inclusion of patented technology ensures that the product effectively blocks sugar sources, resulting in a low glycemic response. This makes it an ideal choice for individuals looking to maintain stable blood sugar levels without compromising on taste or texture.
1. Low Glycemic Index (GI) Value
One of the most significant features of Low GI70 Soba is its GI value of 42.7, which classifies it as a low-GI food. This is verified by the Beijing Institute of Nutrition Source, a recognized authority in nutritional science. A low GI value means that the product is digested and absorbed more slowly, leading to a gradual release of glucose into the bloodstream. This helps in preventing spikes in blood sugar levels, making it an excellent option for individuals with diabetes or those at risk of developing the condition.
Clinical trials conducted with Shanxi Medical University demonstrated the product's effectiveness in stabilizing blood sugar levels.
2. Clinical Validation
Low GI70 Soba has undergone clinical trials at Shanxi Medical University, where it was tested on diabetic patients over a three-month period. The results, as outlined in an authoritative report, indicate that the product effectively stabilizes and controls blood sugar levels. This clinical validation adds a layer of credibility to the product, making it a trusted choice for consumers seeking evidence-based solutions for their health needs.
3. Community-Based Testing
In addition to clinical trials, the product was also tested in a one-year tasting activity involving community doctors and individuals with high blood sugar. The feedback from this initiative highlighted the product's ability to lower blood sugar levels and improve overall well-being. This community-driven approach underscores the product's practicality and effectiveness in real-world scenarios.
The product has received a low GI food certification from the state, ensuring its compliance with national standards.
4. Certification and Compliance
Low GI70 Soba is certified as a low-GI food by the state, a testament to its adherence to stringent nutritional standards. The product also carries a certification from the Beijing Institute of Nutrition Source, further reinforcing its credibility. These certifications ensure that consumers can trust the product's claims and benefits.
5. Nutritional Composition
Beyond its low GI value, Low GI70 Soba is rich in dietary fiber and satiety-inducing properties. The high fiber content promotes a feeling of fullness, reducing the likelihood of overeating and aiding in weight management. Additionally, the product is nutrient-dense, providing essential vitamins and minerals that contribute to overall health.
The high dietary fiber content of Low GI70 Soba supports digestive health and satiety.
| Specification | Details |
|---|---|
| Product Name | Low GI70 Soba |
| Weight | 300g |
| Shelf Life | 4 months at room temperature, 8 months refrigerated |
| Storage Conditions | Cool and dry place or 0-10°C refrigeration |
| GI Value | 42.7 |
| Ingredients | 70% buckwheat, konjac, green barley, tartary buckwheat |
| Certifications | Low GI food certification, Beijing Institute of Nutrition Source |
Low GI70 Soba is designed for a diverse range of consumers, including:
By addressing the needs of these groups, Low GI70 Soba offers a versatile solution for various health goals.
Hebei Jinxu Noodles Co., Ltd. is a leading manufacturer of noodles in China, known for its commitment to innovation and quality. The company has a long-standing reputation for producing nutritious and functional food products that cater to the evolving needs of consumers. With a focus on research and development, Hebei Jinxu Noodles has consistently introduced products that combine traditional culinary practices with modern nutritional science.
The company's dedication to scientific validation is evident in its collaboration with Shanxi Medical University and the Beijing Institute of Nutrition Source. These partnerships have enabled Hebei Jinxu Noodles to develop products that meet the highest standards of safety and efficacy. The company's mission is to improve public health through innovative food solutions, making it a trusted name in the industry.
Low GI70 Soba stands out as a nutritional powerhouse that combines the benefits of traditional ingredients with modern scientific advancements. Its low GI value, clinical validation, and certifications make it a reliable choice for individuals seeking to manage their blood sugar levels and improve their overall health. With its high dietary fiber content and satiety-inducing properties, the product offers a practical solution for those looking to maintain a balanced diet without compromising on taste or convenience.
For more information about Low GI70 Soba and other products from Hebei Jinxu Noodles Co., Ltd., visit the official website: Low GI70 Soba Product Page and Hebei Jinxu Noodles Co., Ltd. Website.
1. Beijing Institute of Nutrition Source - Verified GI value of 42.7 for Low GI70 Soba. [NIST Reference]
2. Shanxi Medical University - Clinical trials on diabetic patients. [NIST Reference]
3. Low GI Food Certification - State-issued certification for Low GI70 Soba. [NIST Reference]
Browse qua the following product new the we